Image-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene

Human Gene Therapy

Volumn 22, Issue 12, 2011, Pages 1563-1574

  Klutz, Kathrin ^a   Willhauck, Michael J ^a   Dohmen, Christian ^a   Wunderlich, Nathalie ^a   Knoop, Kerstin ^a   Zach, Christian ^a   Senekowitsch Schmidtke, Reingard ^b   Gildehaus, Franz Josef ^a   Ziegler, Sibylle ^b   Fürst, Sebastian ^b   Göke, Burkhard ^a   Wagner, Ernst ^a   Ogris, Manfred ^a   Spitzweg, Christine ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; MACROGOL; POLYETHYLENEIMINE; RADIOACTIVE IODINE; SODIUM IODIDE SYMPORTER; TUMOR ANTIGEN;

ARTICLE; CANCER CELL; CONTROLLED STUDY; FEMALE; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CANCER; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR GROWTH;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; COMBINED MODALITY THERAPY; DRUG DELIVERY SYSTEMS; FLUORESCENT ANTIBODY TECHNIQUE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; IODINE RADIOISOTOPES; LIVER NEOPLASMS; MICE; MICE, NUDE; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOTHERAPY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYMPORTERS; TUMOR CELLS, CULTURED;

EID: 83455169260     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2011.041     Document Type: Article

References (61)

1. Akinc, A., Thomas, M., Klibanov, A.M., and Langer R. (2005). Exploring polyethylenimine-mediated DNA transfection and proton sponge hypothesis. J. Gene Med. 7, 657-663. (Pubitemid 40744532)
2. Baril, P., Martin-Duque, P., and Vassaux, G. (2010). Visualization of gene expression in the live subject using the Na/I sym-porter as a reporter gene: Applications in biotherapy. Br. J. Pharmacol. 159, 761-771.
3. Blechacz, B., Splinter, P.L., Greiner, S., et al. (2006). Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma. Hepatology 44, 1465-1477. (Pubitemid 44953652)
4. Boland, A., Ricard, M., Opolon, P., et al. (2000). Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res. 13, 3484-3492. (Pubitemid 30482168)
5. Brunner, S., Sauer, T., Carotta, S., et al. (2000). Cell cycle dependence of gene transfer by lipoplex, polyplex and recom-binant adenovirus. Gene Ther. 7, 401-407. (Pubitemid 30156552)
6. Carlson, S.K., Classic, K.L., Hadac, et al. (2006). In vivo quanti-tation of intratumoral radioisotope uptake using micro-single photon emission computed tomography/computed tomography. Mol. Imaging Biol. 8, 324-332. (Pubitemid 44741369)
7. Carlson, S.K., Classic, K.L., Hadac, E.M., et al. (2009). Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter gene. AJR Am. J. Roentgenol. 192, 279-287.
8. Cengic, N., Baker, C.H., Schutz, M., et al. (2005). A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression. J. Clin. Endocrinol. Metab. 90, 4457-4464. (Pubitemid 41159327)
9. Chen, L., Altmann, A., Mier, W., et al. (2006). Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene. J. Nucl. Med. 47, 854-862. (Pubitemid 46768449)
10. Chisholm, E.J., Vassaux, G., Martin-Duque, P., et al. (2009). Cancer-specific transgene expression mediated by systemic injection of nanoparticles. Cancer Res. 69, 2655-2662.
11. Chollet, P., Favrot, M.C., Hurbin, A., and Coll, J.L. (2002). Side-effects of systemic injection of linear polyethylenimine-DNA complexes. J. Gene Med. 4, 84-91. (Pubitemid 40277159)
12. Dai, G., Levy, O., and Carrasco, N. (1996). Cloning and characterization of the thyroid iodide transporter. Nature 379, 458-460. (Pubitemid 26039527)
13. Dingli, D., Russell, S.J., and Morris, J.C., III. (2003). In vivo imaging and tumor therapy with the sodium iodide symporter. J. Cell Biochem. 90, 1079-1086. (Pubitemid 37485046)
14. Dingli, D., Peng, K.-W., Harvey, M.E., et al. (2004). Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide sym-porter. Blood 103, 1641-1646. (Pubitemid 38268954)
15. Dufes, C., Keith, W.N., Bilsland, A., et al. (2005). Synthetic anti-cancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors. Cancer Res. 65, 8079-8084. (Pubitemid 41330568)
16. Dwyer, R.M., Bergert, E.R., O'Connor, M.K., et al. (2005). In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide sympor-ter. Clin. Cancer Res. 11, 1483-1489. (Pubitemid 40315230)
17. Faivre, J., Clerc, J., Gerolami, R., et al. (2004). Long-term radio-iodine retention and regression of liver cancer after sodium iodide symporter gene transfer in Wistar rats. Cancer Res. 64, 8045-8051. (Pubitemid 39446941)
18. Gerolami, R., Uch, R., Brechot, C., et al. (2003). Gene therapy of hepatocarcinoma: A long way from the concept to the therapeutical impact. Cancer Gene Ther. 10, 649-660. (Pubitemid 37129453)
19. Goel, A., Carlson, S.K., Classic, K.L., et al. (2007). Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(D51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene. Blood 110, 2342-2350. (Pubitemid 47523154)
20. Groot-Wassink, T., Aboagye, E.O., Wang, Y., et al. (2004). Quantitative imaging of Na/I symporter transgene expression using positron emission tomography in the living animal. Mol. Ther. 9, 436-442. (Pubitemid 38404533)
21. Guo, W., and Lee, R.J. (1999). Receptor-targeted gene delivery via folate-conjugated polyethylenimine. AAPS PharmSci. 1, E19.
22. Herve, J., Cunha, A.S., Liu, B., et al. (2008). Internal radiotherapy of liver cancer with rat hepatocarcinoma-intestine-pancreas gene as a liver tumor-specific promoter. Hum. Gene Ther. 19, 915-926.
23. Hingorani, M., Spitzweg, C., Vassaux, G., et al. (2010). The biology of the sodium iodide symporter and its potential for targeted gene delivery. Curr. Cancer Drug Targets 10, 242-267.
24. Iyer, A.K., Khaled, G., Fang, J., and Maeda, H. (2006). Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov. Today 11, 812-818. (Pubitemid 44280021)
25. Kloeckner, J., Wagner, E., and Ogris, M. (2006). Degradable gene carriers based on oligomerized polyamines. Eur. J. Pharm. Sci. 29, 414-425. (Pubitemid 44709863)
26. Klutz, K., Russ, V., Willhauck, M.J., et al. (2009). Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene. Clin. Cancer Res. 15, 6079-6086.
27. Klutz, K., Schaffert, D., Willhauck, M.J., et al. (2011a). Epidermal growth factor receptor-targeted 131I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene. Mol. Ther. 19, 676-685.
28. Klutz, K., Willhauck, M.J., Wunderlich, N., et al. (2011b). Sodium iodide symporter (NIS)-mediated radionuclide 131I, 188Re, therapy of liver cancer after transcriptionally targeted intratumoral in vivo NIS gene delivery. Hum. Gene Ther. (in press).
29. Li, H., Peng, K.W., Dingli, D., et al. (2010). Oncolytic measles viruses encoding interferon b and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy. Cancer Gene Ther. 17, 550-558.
30. Liu, C., Russell, S.J., and Peng, K.W. (2010). Systemic therapy of disseminated myeloma in passively immunized mice using measles virus-infected cell carriers. Mol. Ther. 18, 1155-1164.
31. Marsee, D.K., Shen, D.H., Macdonald, L.R., et al. (2004). Imaging of metastatic pulmonary tumors following NIS gene transfer using single photon emission computed tomography. Cancer Gene Ther. 11, 121-127. (Pubitemid 38141774)
32. Matsumura, Y., and Maeda, H. (1986). A new concept for mac-romolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46, 6387-6392. (Pubitemid 17221789)
33. Merron, A., Peerlinck, I., Martin-Duque, P., et al. (2007). SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene. Gene Ther. 14, 1731-1738. (Pubitemid 350238450)
34. Navarro, G., Maiwald, G., Haase, R., et al. (2010). Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery. J. Control. Release 146, 99-105.
35. Ogris, M., Walker, G., Blessing, T., et al. (2003). Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. J. Control. Release 91, 173-181. (Pubitemid 37288888)
36. Oupicky, D., Parker, A.L., and Seymour, L.W. (2002). Laterally stabilized complexes of DNA with linear reducible polyca-tions: Strategy for triggered intracellular activation of DNA delivery vectors. J. Am. Chem. Soc. 124, 8-9. (Pubitemid 34037536)
37. Peerlinck, I., Merron, A., Baril, P., et al. (2009). Targeted radio-nuclide therapy using a Wnt-targeted replicating adenovirus encoding the Na/I symporter. Clin. Cancer Res. 15, 6595-6601.
38. Penheiter, A.R., Wegman, T.R., Classic, K.L., et al. (2010). Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer. AJR Am. J. Roentgenol. 195, 341-349.
39. Rudolph, C., Schillinger, U., Plank, C., et al. (2002). Nonviral gene delivery to the lung coploymer-protected and transferrin-modified polyethylenimine. Biochim. Biophys. Acta 1573, 75-83. (Pubitemid 35279791)
40. Russ, V., Elfberg, H., Thoma, C., et al. (2008a). Novel degradable oligoethylenimine acrylate ester-based pseudodendrimers for in vitro and in vivo gene transfer. Gene Ther. 15, 18-29. (Pubitemid 350269429)
41. Russ, V., Gü nther M., Halama A., et al. (2008b). Oligoethylenimine-grafted polypropylenimine dendrimers as degradable and biocompatible synthetic vectors for gene delivery. J. Control. Release 132, 131-140.
42. Scholz, I.V., Cengic, N., Baker, C.H., et al. (2005). Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer. Gene Ther. 12, 272-280. (Pubitemid 40220629)
43. Schwerdt, A., Zintchenko, A., Concia, M., et al. (2008). Hyperthermia-induced targeting of thermosensitive gene carriers to tumors. Hum. Gene Ther. 19, 1283-1292.
44. Shariff, M.I., Cox, I.J., Gomaa, A.I., et al. (2009). Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev. Gastroenterol. Hepatol. 3, 353-367.
45. Smanik, P.A., Liu, Q., Furminger, T.L., et al. (1996). Cloning of the human sodium iodide symporter. Biochem. Biophys. Res. Commun. 226, 339-345. (Pubitemid 26331906)
46. Smrekar, B., Wightman, L., Wolschek, M.F., et al. (2003). Tissue-dependent factors affect gene delivery to tumors in vivo. Gene Ther. 10, 1079-1088. (Pubitemid 36850230)
47. Sonawane, N.D., Szoka, JR F.C., and Verkman, A.S. (2003). Chloride accumulation and swelling in endosome enhances DNA transfer by polyamine-DNA polyplexes. J. Biol. Chem. 278, 44826-44831. (Pubitemid 37377241)
48. Spitzweg, C., and Morris, J.C. (2002). The sodium iodide sym-porter: Its pathophysiological and therapeutic implications. Clin. Endocrinol. 57, 559-574. (Pubitemid 35316971)
49. Spitzweg, C., Zhang, S., Bergert, E.R., et al. (1999). Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines. Cancer Res. 59, 2136-2141. (Pubitemid 29217677)
50. Spitzweg, C., O'Connor, M.K., Bergert, E.R., et al. (2000). Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Cancer Res. 60, 6526-6530.
51. Spitzweg, C., Dietz, A.B., O'Connor, M.K., et al. (2001). In vivo sodium iodide symporter gene therapy of prostate cancer. Gene Ther. 8, 1524-1531. (Pubitemid 33061890)
52. Spitzweg, C., Baker, C.H., Bergert, E.R., et al. (2007). Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression. Hum. Gene Ther. 18, 916-924. (Pubitemid 47587318)
53. Trujillo, M.A., O'Neal, M.J., McDonough, S., et al. (2010). A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radio-virotherapy of prostate cancer. Gene Ther. 17, 1325-1332.
54. Van Nostrand, D., and Wartofsky, L. (2007). Radioiodine in the treatment of thyroid cancer. Endocrinol. Metab. Clin. North Am. 36, 807-822. (Pubitemid 47126256)
55. Wapnir, I.L., Goris, M., Yudd, A., et al. (2004). The Na+/I-symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid. Clin. Cancer Res. 10, 4294-4302. (Pubitemid 38878866)
56. Watanabe, Y., Horie, S., Funaki, Y., et al. (2010). Delivery of Na/I symporter gene into skeletal muscle using nanobubbles and ultrasound: Visualization of gene expression by PET. J. Nucl. Med. 51, 951-958.
57. Willhauck, M.J., Sharif Samani, B.R., Gildehaus, F.J., et al. (2007). Application of 188rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression. J. Clin. Endocrinol. Metab. 92, 4451-4458. (Pubitemid 350074769)
58. Willhauck, M.J., Samani, B.R., Wolf, I., et al. (2008a). The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer. Eur. J. Nucl. Med. Mol. Imaging 35, 1272-1281.
59. Willhauck, M.J., Sharif Samani, B.R., Klutz, K., et al. (2008b). a-Fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma. Gene Ther. 15, 214-223. (Pubitemid 351150044)
60. Willhauck, M.J., Sharif-Samani, B., Senekowitsch-Schmidtke, R., et al. (2008c). Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone. Breast Cancer Res. Treat. 109, 263-272. (Pubitemid 351644845)
61. Zintchenko, A., Susha, A.S., Concia, M., et al. (2009). Drug na-nocarriers labeled with near-infrared-emitting quantum dots (quantoplexes): imaging fast dynamics of distribution in living animals. Mol. Ther. 17, 1849-1856.